Anuroop Packaging Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 1, 2025, 2:32 pm

Quick Insight

Anuroop Packaging Ltd, with a share price of ₹21.3 and a market cap of 23.5 Cr., presents an intriguing investment opportunity in the Packaging & Containers sector. The company's low P/E ratio of 5.83 indicates undervaluation, supported by a healthy ROE of 13.9% and ROCE of 16.6%. An impressive operating profit margin of 44.58% underscores operational efficiency, while a moderate debt level with a comfortable interest coverage ratio of 5.33x provides financial stability. With a substantial promoter holding of 48.18% and a reasonable P/BV ratio of 0.49x, Anuroop Packaging appears well-positioned for potential growth, making it a stock worth monitoring closely in the current market environment.

Competitors of Anuroop Packaging Ltd

All Competitor Stocks of Anuroop Packaging Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:59 am

Below is a detailed analysis of the quarterly data for Anuroop Packaging Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 8.30 Cr.. The value appears strong and on an upward trend. It has increased from 3.50 Cr. (Dec 2024) to 8.30 Cr., marking an increase of 4.80 Cr..
• For Expenses, as of Mar 2025, the value is 4.60 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.41 Cr. (Dec 2024) to 4.60 Cr., marking an increase of 2.19 Cr..
• For Operating Profit, as of Mar 2025, the value is 3.70 Cr.. The value appears strong and on an upward trend. It has increased from 1.09 Cr. (Dec 2024) to 3.70 Cr., marking an increase of 2.61 Cr..
• For OPM %, as of Mar 2025, the value is 44.58%. The value appears strong and on an upward trend. It has increased from 31.14% (Dec 2024) to 44.58%, marking an increase of 13.44%.
• For Other Income, as of Mar 2025, the value is 0.35 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.35 Cr..
• For Interest, as of Mar 2025, the value is 0.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.42 Cr. (Dec 2024) to 0.38 Cr., marking a decrease of 0.04 Cr..
• For Depreciation, as of Mar 2025, the value is 0.26 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.26 Cr..
• For Profit before tax, as of Mar 2025, the value is 3.41 Cr.. The value appears strong and on an upward trend. It has increased from 0.76 Cr. (Dec 2024) to 3.41 Cr., marking an increase of 2.65 Cr..
• For Tax %, as of Mar 2025, the value is 26.69%. The value appears to be improving (decreasing) as expected. It has decreased from 55.26% (Dec 2024) to 26.69%, marking a decrease of 28.57%.
• For Net Profit, as of Mar 2025, the value is 2.50 Cr.. The value appears strong and on an upward trend. It has increased from 0.33 Cr. (Dec 2024) to 2.50 Cr., marking an increase of 2.17 Cr..
• For EPS in Rs, as of Mar 2025, the value is 2.26. The value appears strong and on an upward trend. It has increased from 0.30 (Dec 2024) to 2.26, marking an increase of 1.96.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:58 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:52 pm

Below is a detailed analysis of the balance sheet data for Anuroop Packaging Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.05 Cr.. The value appears strong and on an upward trend. It has increased from 10.66 Cr. (Mar 2024) to 11.05 Cr., marking an increase of 0.39 Cr..
• For Reserves, as of Mar 2025, the value is 21.50 Cr.. The value appears strong and on an upward trend. It has increased from 15.06 Cr. (Mar 2024) to 21.50 Cr., marking an increase of 6.44 Cr..
• For Borrowings, as of Mar 2025, the value is 15.03 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 14.63 Cr. (Mar 2024) to 15.03 Cr., marking an increase of 0.40 Cr..
• For Other Liabilities, as of Mar 2025, the value is 3.77 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.60 Cr. (Mar 2024) to 3.77 Cr., marking an increase of 1.17 Cr..
• For Total Liabilities, as of Mar 2025, the value is 51.35 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 42.95 Cr. (Mar 2024) to 51.35 Cr., marking an increase of 8.40 Cr..
• For Fixed Assets, as of Mar 2025, the value is 10.11 Cr.. The value appears to be declining and may need further review. It has decreased from 11.15 Cr. (Mar 2024) to 10.11 Cr., marking a decrease of 1.04 Cr..
• For CWIP, as of Mar 2025, the value is 4.71 Cr.. The value appears strong and on an upward trend. It has increased from 2.08 Cr. (Mar 2024) to 4.71 Cr., marking an increase of 2.63 Cr..
• For Investments, as of Mar 2025, the value is 15.49 Cr.. The value appears strong and on an upward trend. It has increased from 13.49 Cr. (Mar 2024) to 15.49 Cr., marking an increase of 2.00 Cr..
• For Other Assets, as of Mar 2025, the value is 21.04 Cr.. The value appears strong and on an upward trend. It has increased from 16.23 Cr. (Mar 2024) to 21.04 Cr., marking an increase of 4.81 Cr..
• For Total Assets, as of Mar 2025, the value is 51.35 Cr.. The value appears strong and on an upward trend. It has increased from 42.95 Cr. (Mar 2024) to 51.35 Cr., marking an increase of 8.40 Cr..

Notably, the Reserves (21.50 Cr.) exceed the Borrowings (15.03 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Anuroop Packaging Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 3.64. This value is below the healthy minimum of 5. It has decreased from 3.84 (Mar 24) to 3.64, marking a decrease of 0.20.
• For Diluted EPS (Rs.), as of Mar 25, the value is 3.64. This value is below the healthy minimum of 5. It has decreased from 3.84 (Mar 24) to 3.64, marking a decrease of 0.20.
• For Cash EPS (Rs.), as of Mar 25, the value is 4.63. This value is within the healthy range. It has increased from 4.59 (Mar 24) to 4.63, marking an increase of 0.04.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.45. It has increased from 24.12 (Mar 24) to 29.45, marking an increase of 5.33.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.45. It has increased from 24.12 (Mar 24) to 29.45, marking an increase of 5.33.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 16.58. It has decreased from 26.12 (Mar 24) to 16.58, marking a decrease of 9.54.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 7.59. This value is within the healthy range. It has increased from 6.76 (Mar 24) to 7.59, marking an increase of 0.83.
• For PBIT / Share (Rs.), as of Mar 25, the value is 6.62. This value is within the healthy range. It has increased from 5.99 (Mar 24) to 6.62, marking an increase of 0.63.
• For PBT / Share (Rs.), as of Mar 25, the value is 5.20. This value is within the healthy range. It has increased from 4.77 (Mar 24) to 5.20, marking an increase of 0.43.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 3.66. This value is within the healthy range. It has decreased from 3.83 (Mar 24) to 3.66, marking a decrease of 0.17.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.66. This value is within the healthy range. It has decreased from 3.83 (Mar 24) to 3.66, marking a decrease of 0.17.
• For PBDIT Margin (%), as of Mar 25, the value is 45.77. This value is within the healthy range. It has increased from 25.87 (Mar 24) to 45.77, marking an increase of 19.90.
• For PBIT Margin (%), as of Mar 25, the value is 39.92. This value exceeds the healthy maximum of 20. It has increased from 22.94 (Mar 24) to 39.92, marking an increase of 16.98.
• For PBT Margin (%), as of Mar 25, the value is 31.33. This value is within the healthy range. It has increased from 18.26 (Mar 24) to 31.33, marking an increase of 13.07.
• For Net Profit Margin (%), as of Mar 25, the value is 22.06. This value exceeds the healthy maximum of 10. It has increased from 14.64 (Mar 24) to 22.06, marking an increase of 7.42.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 22.06. This value exceeds the healthy maximum of 20. It has increased from 14.64 (Mar 24) to 22.06, marking an increase of 7.42.
• For Return on Networth / Equity (%), as of Mar 25, the value is 12.42. This value is below the healthy minimum of 15. It has decreased from 15.85 (Mar 24) to 12.42, marking a decrease of 3.43.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.81. This value is within the healthy range. It has decreased from 18.25 (Mar 24) to 17.81, marking a decrease of 0.44.
• For Return On Assets (%), as of Mar 25, the value is 7.87. This value is within the healthy range. It has decreased from 9.49 (Mar 24) to 7.87, marking a decrease of 1.62.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.23. This value is within the healthy range. It has decreased from 0.34 (Mar 24) to 0.23, marking a decrease of 0.11.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.46. This value is within the healthy range. It has decreased from 0.56 (Mar 24) to 0.46, marking a decrease of 0.10.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.38. It has decreased from 0.67 (Mar 24) to 0.38, marking a decrease of 0.29.
• For Current Ratio (X), as of Mar 25, the value is 1.97. This value is within the healthy range. It has increased from 1.95 (Mar 24) to 1.97, marking an increase of 0.02.
• For Quick Ratio (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 1.66 (Mar 24) to 1.73, marking an increase of 0.07.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 4. It has decreased from 4.94 (Mar 24) to 0.79, marking a decrease of 4.15.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.33. This value is within the healthy range. It has decreased from 5.53 (Mar 24) to 5.33, marking a decrease of 0.20.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.57. This value is within the healthy range. It has decreased from 4.13 (Mar 24) to 3.57, marking a decrease of 0.56.
• For Enterprise Value (Cr.), as of Mar 25, the value is 30.80. It has decreased from 34.34 (Mar 24) to 30.80, marking a decrease of 3.54.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.68. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.68, marking an increase of 0.45.
• For EV / EBITDA (X), as of Mar 25, the value is 3.67. This value is below the healthy minimum of 5. It has decreased from 4.76 (Mar 24) to 3.67, marking a decrease of 1.09.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.87. This value is below the healthy minimum of 1. It has increased from 0.72 (Mar 24) to 0.87, marking an increase of 0.15.
• For Price / BV (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.78 (Mar 24) to 0.49, marking a decrease of 0.29.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.87. This value is below the healthy minimum of 1. It has increased from 0.72 (Mar 24) to 0.87, marking an increase of 0.15.
• For EarningsYield, as of Mar 25, the value is 0.25. This value is below the healthy minimum of 5. It has increased from 0.20 (Mar 24) to 0.25, marking an increase of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness